Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: a nationwide real-world study
一线西妥昔单抗治疗RAS野生型转移性结直肠癌老年患者(≥70岁)的疗效和安全性:一项全国性真实世界研究
期刊:American Journal of Cancer Research
影响因子:2.9
doi:10.62347/QZFD8646
Huang, Ching-Wen; Chen, Chou-Chen; Chang, Shih-Ching; Chang, Yu-Yao; Lin, Bo-Wen; Chen, Hong-Hwa; Hsieh, Yao-Yu; Hsu, Hung-Chih; Hsieh, Meng-Che; Ke, Tao-Wei; Kuan, Feng-Che; Wu, Chih-Chien; Lu, Wei-Chen; Su, Yu-Li; Liang, Yi-Hsin; Chen, Joe-Bin; Huang, Shuan-Yuan; Chen, Po-Jung; Wang, Jaw-Yuan